AV-Comparatives Announces Outstanding Results of Cybersecurity Solutions in 2024 Endpoint Prevention and Response (EPR) Test

AV-Comparatives Announces Outstanding Results of Cybersecurity Solutions in 2024 Endpoint Prevention and Response (EPR) Test

Download the full report here. INNSBRUCK, Austria, Dec. 12, 2024 /PRNewswire/ -- AV-Comparatives, the globally recognized authority in independent cybersecurity testing, has released its 2024 Endpoint Prevention and Response (EPR) Comparative...

Baijiayun Announces Up To $15 Million Convertible Promissory Notes And $50 Million Standby Equity Purchase Agreement

Baijiayun Announces Up To $15 Million Convertible Promissory Notes And $50 Million Standby Equity Purchase Agreement

BEIJING, Dec. 7, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that it has entered into a Standby Equity Purchase Agreement (the "SEPA"), with YA II PN,...

AV-Comparatives Announces 2024 Phishing Test Results: Avast and McAfee Excel in Yearly Assessment

AV-Comparatives Announces 2024 Phishing Test Results: Avast and McAfee Excel in Yearly Assessment

INNSBRUCK, Austria, Dec. 3, 2024 /PRNewswire/ -- AV-Comparatives, a leading independent organisation for IT security testing, has published the results of its comprehensive 2024 phishing protection tests. Over the year, 1,000 phishing URLs were...

3DMakerpro Debuts Eagle Spatial Scanner at Formnext 2024, Announces Sponsorship of Singapore Centre for 3D Printing

3DMakerpro Debuts Eagle Spatial Scanner at Formnext 2024, Announces Sponsorship of Singapore Centre for 3D Printing

FRANKFURT, Germany, Nov. 27, 2024 /PRNewswire/ -- 3DMakerpro, a trailblazer in consumer-friendly 3D scanning technology, made a remarkable impression at Formnext 2024, the leading international trade fair for Additive Manufacturing and industrial 3D...

Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024

Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024

SAN FRANCISCO and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

Nature's Miracle Holding Inc. Announces $2.0 Million Debt to Equity Conversion by Management and Related Debt Holders

Nature's Miracle Holding Inc. Announces $2.0 Million Debt to Equity Conversion by Management and Related Debt Holders

ONTARIO, Calif., Nov. 20, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, announced today that the Company's management team and...

  • 1
  • 2
  • menu
    menu